Lilly Sues USPTO For Extra 1.5 Years On Cancer Patent
Drugmaker Eli Lilly & Co. sued the U.S. Patent and Trademark Office in Virginia federal court Tuesday, claiming the agency acted arbitrarily in failing to extend its patent for a cancer...To view the full article, register now.
Already a subscriber? Click here to view full article